Dragons Blood Capsule compound stable angina randomized controlled multicenter clinical study.docVIP

 PAGE \* MERGEFORMAT 14 Dragon’s Blood Capsule compound stable angina randomized controlled multicenter clinical study Of: Qing Hui, Fan Junming, Wang Shoufu, Duting Hai, Ma Chunlin, Xu Zhong white, Wang Shaping [Abstract] Objective To evaluate the compound of Dragon’s Blood Capsule stable angina pectoris (blood stasis syndrome) the effectiveness and safety. Methods A randomized, double-blind, positive parallel controlled, multicenter clinical study, 418 cases of the experimental group (314 cases) of Dragon’s Blood Capsules compound given orally, the control group (104 patients) with oral Danshen capsules daily for 28 d. The results are angina and ECG test group significantly better than the control group (P lt;0.05), while the TCM syndromes, nitroglycerin stopped by rate between the 2 groups was no significant difference (Pgt; 0.05). test group no serious adverse events. Conclusion The compound of Dragon’s Blood Capsules in the treatment of stable angina pain (Xinmaitong stasis) is effective and safe. [Keywords:] stable angina, the compound of Dragon’s Blood Capsules, randomized controlled trials, effort stasis Abstract: Objective To evaluate the therapeutic effect and safety of Compound Longxuejie Capsules for treatment of stable angina pectoris with cariac blood stasis syndrome. Methods A randomized, double-blind, positive drug parallel controlled, multi-center clinical trial was adopted. 418 patients with stable angina pectoris with cariac blood stasis syndrome were randomly chosen and divided into two groups: test group (314 cases) and control group (104 cases). The test group was treated with Compound Longxuejie Capsules and the control group received Compound Danshen Capsules. Treatment course of each group was 28 days. Results The antiangina effect and changes electrocardiogram in test group were better than that of the control group (P lt;0.05), but was almost the same as the control group in the effective rate of TCM syndrome and the dosag